HighMark Wealth Management »

Neuropace shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $21k 3.0k 6.97

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Paragon 28 (FNA)
Performant Finl (PFMT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
AtriCure (ATRC)
Apple (AAPL)

View all positions for HighMark Wealth Management

Top funds holding Neuropace

OrbiMed Advisors
Morgan Stanley
Soleus Capital Management
Kent Lake PR
Kent Lake Capital
Vanguard Group
BlackRock
BlackRock
Nantahala Capital Management
Deutsche Bank Aktiengesellschaft
Geode Capital Management
Northern Trust
State Street Corporation
Renaissance Technologies
Charles Schwab Investment Management

View all funds holding Neuropace